Shareholders will be ecstatic, with their stake up 35% over the past week following SYNLAB AG's (FRA:SYAB) latest full-year results. Statutory earnings per share fell badly short of expectations, ...

This understanding is driving a shift from isolated tests to comprehensive diagnostic panels; carefully structured groups of ...

Synlab Italia has suspended all its medical diagnostic and testing services after a ransomware attack forced its IT systems to be taken offline. Part of the Synlab group that is present in 30 ...

The issuer is solely responsible for the content of this announcement. Total offer volume of EUR 772 million, assuming full exercise of Greenshoe option Offer price implies a total market ...

SYNLAB AG (ETR:SYAB), is not the largest company out there, but it received a lot of attention from a substantial price increase on the XTRA over the last few months. With many analysts covering the ...

Cinven has agreed to sell an indirect minority stake in Synlab, a medical diagnostic services and specialty testing provider in Europe, to Labcorp. The purchase price for this 15 percent stake was ...

SYNLAB AG (“SYNLAB” or “the Group”, FSE: SYAB), the leader in medical diagnostic services and specialty testing in Europe, today announced its unaudited Q1 2024 results. The Group reports strong ...

Cinven agreed to buy out Synlab AG for about €1.27 billion ($1.3 billion) two years after listing the German laboratory operator, which has been suffering from reduced demand for its testing ...

Laboratory services group Synlab on Monday guided investors to expect its planned initial public offering to price at the bottom of the marketing range, cutting the offer size by a quarter due to ...

Laboratory services group Synlab has priced its initial public offering at 18 euros ($21.76) a share, it said on Tuesday, marking the lower end of a pricing range due to sluggish investor demand.

Synlab has set the price range for its planned initial public offering in Frankfurt at €18 to €23 a share, giving Europe’s largest laboratory services provider a market capitalization of up to €5 ...

Cinven has agreed to sell a minority stake in Synlab, a medical diagnostic services and specialty testing provider, to financial investor Elliott Advisors (UK). Munich-based Synlab provides a full ...